Promacta, also known by its generic name eltrombopag, is a medication used to treat low platelet counts in individuals with chronic immune thrombocytopenia (ITP) and hepatitis C-related thrombocytopenia. This medication is a synthetic thrombopoietin receptor agonist that works by causing the bone marrow to produce more platelets. While Promacta can be effective in treating these conditions, it also comes with potential side effects and warnings that must be considered.
Uses
Promacta is used to treat low platelet counts in individuals with chronic immune thrombocytopenia (ITP) and hepatitis C-related thrombocytopenia. ITP is a condition in which the immune system mistakenly attacks and destroys blood platelets, leading to a decreased ability for the blood to clot. This can cause bruising, bleeding, and sometimes life-threatening hemorrhaging. The low platelet count in hepatitis C-related thrombocytopenia is caused by the hepatitis C virus, which negatively affects platelet production. Promacta can help to increase platelet counts and reduce the risk of bleeding associated with these conditions.
Benefits
The main benefit of Promacta is its ability to increase platelet counts in individuals with low platelet counts caused by ITP or hepatitis C-related thrombocytopenia. This can help to reduce the risk of bleeding and associated complications. Promacta has also been shown to reduce the need for other treatments, such as corticosteroids and immunoglobulins, which can have negative side effects. By reducing dependence on these treatments, the overall quality of life for individuals with ITP or hepatitis C-related thrombocytopenia may be improved.
Side Effects
While Promacta can be effective in increasing platelet counts, it also comes with potential side effects that must be considered. Some of the most commonly reported side effects of Promacta include headache, nausea, diarrhea, abdominal pain, and insomnia. Other side effects can include changes in liver function tests, skin rash, and cataracts. In rare cases, Promacta can cause liver problems, including jaundice, hepatitis, and liver failure.
Warnings
Before using Promacta, it is important to consider the potential risks and warnings associated with this medication. Promacta can cause liver problems, so it is important to have regular blood tests to monitor liver function while using this medication. If liver problems are detected, Promacta may need to be stopped. This medication can also increase the risk of blood clots, so it should not be used in individuals with a history of blood clots or those who are at high risk for blood clots. Promacta should also be used with caution in individuals with a history of bleeding disorders or those taking anticoagulants.
FAQs
It may take several weeks for Promacta to start working. Platelet counts should be monitored regularly to determine if the medication is working as intended.
Promacta is approved for use in individuals over the age of 6 with chronic immune thrombocytopenia.
Promacta is taken orally once daily with or without food.
The safety of Promacta use during pregnancy has not been established, and it is not recommended for use in pregnant women unless the benefits outweigh the risks.
Promacta should be used with caution in individuals with liver problems. Liver function should be monitored regularly while using this medication.
